"Il Polo di radioterapia oncologica di via Emilio Longoni, rinnovato anche negli spazi dedicati ai pazienti, è una struttura completamente convenzionata con il Servizio Sanitario Nazionale che occupa una superficie di circa 1400 metri quadrati e garantisce oltre 90mila prestazioni annue, con servizi destinati al bacino di utenza delle regioni del Centro-Sud Italia, oltre a Roma e al Lazio."

During the past decade, Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" are "Breast Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Small Cell Lung Carcinoma" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (3 trials), "Docetaxel" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".